Sign up for our free daily newsletter


Get the latest news and some fun stuff
in your inbox every day

J&J Buys Robotics Maker

We often talk about Stryker as a consolidator in the Medical Devices arena. But let's not forget that Johnson & Johnson has a $27bn per annum medical devices behemoth that is, in fact, twice the size of Stryker. Stryker has annual sales of $13.6bn.

Earlier this week it was announced that J&J Acquires Robotic-Surgery Firm Auris for $3.4bn.

Auris makes robotic surgical scopes operated with a handheld device used to identify cancerous tumours on peoples lungs.



The deal value could increase by $2.35bn if certain targets are met. As we have said before, this sector has the most incredible innovations but unless you work in the field you are not exposed to it. Even the patients have no idea what devices are being used. We are very excited by the developments taking place within the medical devices area and are happy holders of J&J and Stryker in this sector.


Other recommended stocks     Other stories about JNJ